biliary tract cancer
Recently Published Documents

TOTAL DOCUMENTS

1395
(FIVE YEARS 178)

H-INDEX

52
(FIVE YEARS 3)
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

scholarly journals Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100314
Author(s):  
M.M. Javle ◽  
D.-Y. Oh ◽  
M. Ikeda ◽  
W.-P. Yong ◽  
K. Hsu ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Second Line ◽  
Tract Cancer ◽  
Randomized Phase Ii

Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial

2022 ◽  
Vol 162 ◽  
pp. 161-169
Author(s):  
Sophie Cousin ◽  
Coralie Cantarel ◽  
Jean-Philippe Guegan ◽  
Thibault Mazard ◽  
Carlos Gomez-Roca ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Trial ◽  
Open Label ◽  
Tract Cancer ◽  
Open Label Phase

scholarly journals How I treat biliary tract cancer

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100378
Author(s):  
A. Lamarca ◽  
J. Edeline ◽  
L. Goyal
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Tract Cancer

ASO Visual Abstract: ACAT-1-Regulated Cholesteryl Ester Accumulation Modulates Gemcitabine Resistance in Biliary Tract Cancer

2022 ◽  
Author(s):  
Goro Ueno ◽  
Yoshifumi Iwagami ◽  
Shogo Kobayashi ◽  
Suguru Mitsufuji ◽  
Daisaku Yamada ◽  
...  
Keyword(s):  
Cholesteryl Ester ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Tract Cancer ◽  
Gemcitabine Resistance ◽  
Cholesteryl Ester Accumulation

scholarly journals Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis

Gut and Liver ◽  
2022 ◽  
Author(s):  
Kwangrok Jung ◽  
Jaewoo Park ◽  
Jae Hyup Jung ◽  
Jong-Chan Lee ◽  
Jaihwan Kim ◽  
...  
Keyword(s):  
Propensity Score ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Real World ◽  
Chemotherapy Regimen ◽  
Tract Cancer

ASO Author Reflections: ACAT-1-Regulated Cholesteryl Ester Accumulation Modulates Gemcitabine Resistance in Biliary Tract Cancer

2022 ◽  
Author(s):  
Goro Ueno ◽  
Yoshifumi Iwagami ◽  
Shogo Kobayashi ◽  
Suguru Mitsufuji ◽  
Daisaku Yamada ◽  
...  
Keyword(s):  
Cholesteryl Ester ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Tract Cancer ◽  
Gemcitabine Resistance ◽  
Cholesteryl Ester Accumulation

ACAT-1-Regulated Cholesteryl Ester Accumulation Modulates Gemcitabine Resistance in Biliary Tract Cancer

2022 ◽  
Author(s):  
Goro Ueno ◽  
Yoshifumi Iwagami ◽  
Shogo Kobayashi ◽  
Suguru Mitsufuji ◽  
Daisaku Yamada ◽  
...  
Keyword(s):  
Cholesteryl Ester ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Tract Cancer ◽  
Gemcitabine Resistance ◽  
Cholesteryl Ester Accumulation

Second-line liposomal irinotecan plus fluorouracil and leucovorin in metastatic biliary tract cancer

2022 ◽  
Vol 23 (1) ◽  
pp. e11
Author(s):  
Alessandro Rizzo ◽  
Angela Dalia Ricci ◽  
Giovanni Brandi
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Second Line ◽  
Tract Cancer ◽  
Liposomal Irinotecan

scholarly journals Body composition assessment and sarcopenia in patients with biliary tract cancer: A systematic review and meta-analysis

2021 ◽  
Author(s):  
Jun Watanabe ◽  
Ryota Matsui ◽  
Hideki Sasanuma ◽  
Yoichi Ishizaki ◽  
Tetsu Fukunaga ◽  
...  
Keyword(s):  
Systematic Review ◽  
Body Composition ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Meta Analysis ◽  
Body Composition Assessment ◽  
Tract Cancer
Load More ...
Sign in / Sign up

Export Citation Format

Share Document